SLC25A25 and colorectal carcinoma: It was established that SLC25A25-AS1 expression in CRC can influence 5-FU chemoresistance by controlling EMT changes through the Erk/MAPK signalling pathway, in both CRC tissues and cells, but further studies are to be performed as this is the only reported study performed on CRC [204].